Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Repurposing Incyclinide for the Treatment of Hospitalized COVID-19 Patients
The Epigenetic Landscape of Heart Development
Magnetic Field Combinations & Lymphocyte CA++ Signaling
Pyruvate Aldolases in Organic Synthesis
Group Practice in an Academic Center: a Controlled Trial
Recently added grants:
Assessment of EEG Responses to Spinal Cord Stimulation Waveforms in Chronic Pain Patients
The Role of the Tau in Homeostatic Scaling and Mechanisms of Alzheimer's Disease
Risk factors associated with the prevalence of Peri-Implantitis disease
Defining the genetic landscape of nanophthalmos and the role of MYRF
Neuroscientific Exploration of Cultural Protective Factors in American Indians
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67185-2-0-1
Application #
7574879
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ University of Colorado Denver
$385,356
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Badesch, David /
$360,397
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant